Macquarie Healthcare A (DLHAX)
| Fund Assets | 624.17M |
| Expense Ratio | 1.21% |
| Min. Investment | $1,000 |
| Turnover | 5.00% |
| Dividend (ttm) | 3.29 |
| Dividend Yield | 12.61% |
| Dividend Growth | 125.71% |
| Payout Frequency | Annual |
| Ex-Dividend Date | Dec 3, 2024 |
| Previous Close | 24.16 |
| YTD Return | 3.28% |
| 1-Year Return | -5.41% |
| 5-Year Return | 29.32% |
| 52-Week Low | 21.49 |
| 52-Week High | 30.39 |
| Beta (5Y) | 0.58 |
| Holdings | 113 |
| Inception Date | Sep 28, 2007 |
About DLHAX
Macquarie Healthcare Fund Class A is a mutual fund designed to pursue long-term capital growth by investing principally in companies within the healthcare sector. The fund’s portfolio focuses on equity securities of firms engaged in the development, production, or distribution of medical products and services, spanning segments such as pharmaceuticals, biotechnology, medical devices, and healthcare services. Key holdings typically include prominent industry leaders like Eli Lilly and Co, Amgen Inc, and Regeneron Pharmaceuticals, among others. Managed since 2007, the fund employs a strategy that requires at least 80% of its assets to be concentrated in healthcare-related businesses, making it a sector-specific investment vehicle. This focused approach enables the fund to benefit from innovations and demographic trends in healthcare, but it also exposes investors to industry-specific risks, including regulatory changes and evolving medical technologies. With a minimum investment requirement and annual dividend distributions, Macquarie Healthcare Fund Class A serves as a targeted option for those seeking exposure to the healthcare market within a diversified investment portfolio.
Performance
DLHAX had a total return of -5.41% in the past year, including dividends. Since the fund's inception, the average annual return has been 13.06%.
Top 10 Holdings
43.91% of assets| Name | Symbol | Weight |
|---|---|---|
| Eli Lilly and Company | LLY | 6.87% |
| Boston Scientific Corporation | BSX | 6.31% |
| Pfizer Inc. | PFE | 4.29% |
| Chugai Pharmaceutical Co., Ltd. | 4519 | 4.04% |
| Regeneron Pharmaceuticals, Inc. | REGN | 3.82% |
| Merck & Co., Inc. | MRK | 3.79% |
| Elevance Health, Inc. | ELV | 3.79% |
| Roche Holding AG | ROG | 3.78% |
| UnitedHealth Group Incorporated | UNH | 3.62% |
| Gilead Sciences, Inc. | GILD | 3.60% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 3, 2024 | $3.28935 | Dec 4, 2024 |
| Dec 4, 2023 | $1.45736 | Dec 5, 2023 |
| Dec 2, 2022 | $2.274 | Dec 5, 2022 |
| Dec 3, 2021 | $1.476 | Dec 6, 2021 |
| Dec 4, 2020 | $1.553 | Dec 7, 2020 |
| Dec 5, 2019 | $2.015 | Dec 6, 2019 |